ARB-199

N/A

Report date: 2025/04/14 16:51:59
NME

Base Information

Drug NameARB-199
Drug Alias NamecccDNA formation inhibitorsARB-199
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus replication inhibitorscovalently closed circular DNA inhibitors
Targetscovalently closed circular DNA
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBaruch S. Blumberg InstituteDrexel University College of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOnCore Biopharma IncRoivant Sciences LtdArbutus Biopharma Inc +[6] 
Active IndicationsN/A
Inactive IndicationsHepatitis B, ChronicHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A